Faculty of Health and Life Sciences

Dr Chris Jones

Dr Chris Jones

NIHR Academic Clinical Fellow

 C.Jones16@exeter.ac.uk

 Geoffrey Pope 

 

Geoffrey Pope Building, University of Exeter , Stocker Road, Exeter, EX4 4QD, UK

Overview

I am an infection doctor completing specialty training in the South West region. Throughout my career I have developed an interest in tropical diseases and issues of global health importance. Previously I completed a PhD at Imperial College London (Prof Graham Cooke and Dr Marcus Dorner) using novel and established cell culture systems to study hepatitis C virus and resistance to NS5A inhibitors – one of three new classes of direct-acting antivirals that have revolutionised the treatment of HCV. During this period, I was the trial doctor for several HCV interventional studies and worked within a group at the forefront of efforts to achieve elimination of viral hepatitis as a global public health threat by 2030.

I am currently an NIHR Academic Clinical Fellow and have spent time attached to Prof. Elaine Bignell's group at the MRC Centre for Medical Mycology. I am also leading a COG-UK funded genomic epidemiology analysis of nosocomial SARS-CoV-2 transmission at the Royal Devon and Exeter Hospital alongside Dr David Studholme. 

Twitter: @infection_doc

Qualifications

  • BMBS (Bachelor of Medicine, Bachelor of Surgery) 2011
  • MRCP (Member of the Royal College of Physicians) 2014
  • DTM&H (Diploma in Tropical Medicine and Hygiene) 2016
  • DMCC (Diploma in the Medical Care of Catastrophes) 2016
  • PhD (Clinical Medicine Research Infectious Disease) 2020
  • DipRCPath (Diplomate Royal College of Pathologists) 2021
  • PGCert Genomic Medicine (University of Exeter) 2021

Career

2006-11 Undergraduate – Peninsula College of Medicine and Dentistry

2011-13 Foundation Doctor – South Thames Foundation School

2013-15 Core Medical Training – North Central and East London

2015-19 Clinical Research Fellow and PhD student – Imperial College London

2019-21 Specialist Registrar, Combined Infection Training – Peninsula Deanery

2021-ongoing Specialist Registrar, Microbiology – Peninsula Deanery

2019-ongoing NIHR Academic Clinical Fellow Microbiology – Peninsula Deanery

Back to top

Publications

Journal articles

Jones CR, Neill C, Borman AM, Budd EL, Cummins M, Fry C, Guy RL, Jeffery K, Johnson EM, Manuel R, et al (2024). The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England. J Med Microbiol, 73(5). Abstract.  Author URL.
Jones CR, Guy RL, Mirfenderesky M, Brown CS, Lamagni T (2024). Tonsillectomy for recurrent tonsillitis: the NATTINA trial. The Lancet, 403(10437), 1632-1632.
Wang T, Smith DA, Campbell C, Freeman O, Moysova Z, Noble T, Várnai KA, Harris S, Salih H, Roadknight G, et al (2023). Cohort Profile: the National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset. Int J Epidemiol, 52(1), e27-e37.  Author URL.
Campbell C, Wang T, Smith DA, Freeman O, Noble T, Várnai KA, Harris S, Salih H, Roadknight G, Little S, et al (2023). Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK. Wellcome Open Research, 7 Abstract.
Jones CR, Hamilton FW, Thompson A, Morris TT, Moran E (2021). SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis. J Infect, 82(3), e24-e27.  Author URL.
Cooke GS, Pett S, McCabe L, Jones C, Gilson R, Verma S, Ryder SD, Collier JD, Barclay ST, Ala A, et al (2021). Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. Wellcome Open Research, 6, 93-93. Abstract.
Cooke GS, Pett S, McCabe L, Jones C, Gilson R, Verma S, Ryder SD, Collier JD, Barclay ST, Ala A, et al (2021). Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. Wellcome Open Research, 6, 93-93. Abstract.
Cooke GS, Pett S, McCabe L, Jones C, Gilson R, Verma S, Ryder SD, Collier JD, Barclay ST, Ala A, et al (2021). Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT. Efficacy and Mechanism Evaluation, 8(17), 1-90. Abstract.
Smith DA, Wang T, Freeman O, Crichton C, Salih H, Matthews PC, Davies J, Várnai KA, Woods K, Jones CR, et al (2020). National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis research. BMJ Health & Care Informatics, 27(3), e100145-e100145. Abstract.
Jones CR, Hamilton FW, Thompson A, Morris TT, Moran E (2020). Seroprevalence of SARS-CoV-2 IgG in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis. Abstract.
Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, et al (2019). Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol, 4(2), 135-184. Abstract.  Author URL.
Jones CR, Flower BF, Barber E, Simmons B, Cooke GS (2019). Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis. Wellcome Open Research, 4, 132-132. Abstract.
Jones CR, Flower BF, Barber E, Simmons B, Cooke GS (2019). Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis. Wellcome open research, 4 Abstract.
Heffernan A, Barber E, Cook NA, Gomaa AI, Harley YX, Jones CR, Lim AG, Mohamed Z, Nayagam S, Ndow G, et al (2018). Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum. Open Forum Infect Dis, 5(1). Abstract.  Author URL.
Jones CR, Cooke GS (2018). Hepatitis in the traveller. Medicine, 46(1), 20-23.
Jones CR, Cardoso RB, Hüttner E, Oliveira HW, dos Santos MA, Helena Itaqui Lopes M, Russomano T (2012). Towards designing for equity: active citizen participation in eHealth. Transforming Government: People, Process and Policy, 6(4), 333-344. Abstract.

Chapters

Russomano T, B R, R C, W H, Httner E, Itaqui Lopes MH (2011). eHealth Projects of the Microgravity Centre. In  (Ed) Biomedical Engineering, Trends, Research and Technologies, InTech.

Conferences

Jones CR, Ortega-Prieto AM, Cooke G, Dorner M (2019). A phenotypic resistance assay for clinical HCV isolates could help rationalise DAA therapy in individuals experiencing recurrent virologic failure.  Author URL.

Back to top

Office Hours:

9-5 Mon to Fri

Back to top

Edit Profile